Transcat (Transcat) Cash And Cash Equivalents : $35.2 Mil (As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Transcat Cash And Cash Equivalents?

Transcat's quarterly cash and cash equivalents declined from Jun. 2023 ($2.15 Mil) to Sep. 2023 ($1.25 Mil) but then increased from Sep. 2023 ($1.25 Mil) to Dec. 2023 ($35.21 Mil).

Transcat's annual cash and cash equivalents increased from Mar. 2021 ($0.56 Mil) to Mar. 2022 ($1.40 Mil) and increased from Mar. 2022 ($1.40 Mil) to Mar. 2023 ($1.53 Mil).

Transcat Cash And Cash Equivalents Historical Data

The historical data trend for Transcat's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcat Cash And Cash Equivalents Chart

Transcat Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.79

0.50

0.56

1.40

1.53

Transcat Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															1.59	1.53	2.15	1.25	35.21

Transcat Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Transcat (NAS:TRNS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Transcat Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Transcat's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Transcat (Transcat) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Transcat Inc (NAS:TRNS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Vantage Point Drive, Rochester, NY, USA, 14624

Website

https://www.transcat.com

Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.

Executives

Lee D. Rudow	officer: Chief Operating Officer	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
James M. Jenkins	officer: Gen Counsel & VP of Corp Devt	1600 BAUSCH & LOMB PLACE, ROCHESTER NY 14604
Craig D. Cairns	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Dawn Deperrior	director	45 SOUTH MAIN STREET, FAIRPORT NY 14450
Christopher P. Gillette	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Charles P Hadeed	officer: VP-Finance and CFO	35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Scott Deverell	other: Principal Accounting Officer	100 CHESTNUT STREET, SUITE 600, ROCHESTER NY 14604
Richard J Harrison	director	44 SOUTHERN PARKWAY, ROCHESTER NY 14618
Theresa A. Conroy	officer: VP, Human Resources	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Cynthia Langston	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Thomas L Barbato	officer: Sr. VP Finance & CFO	105 NORTON STREET, NEWARK NY 14513
Carl E Sassano	director, officer: Chairman, President and CEO	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Gary J. Haseley	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Michael W. West	officer: VP Distribution & Marketing	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Mbago M. Kaniki	director	C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624